Core Viewpoint - PG&E Corporation (PCG) is set to report its second-quarter 2025 results on July 31, with expectations of revenue and earnings growth despite a previous earnings surprise of -5.71% in the last quarter [1][9]. Factors Influencing Q2 Results - Warmer-than-normal temperatures in PCG's service territories likely increased electricity demand for cooling, positively impacting revenues [2]. - Strong rate-based growth and favorable outcomes from previously approved general rate case filings are expected to contribute to revenue performance [2]. - Efforts to reduce non-fuel operations and maintenance (O&M) expenses may enhance earnings for the quarter [3]. Q2 Expectations - The Zacks Consensus Estimate for sales is $6.37 billion, reflecting a year-over-year growth of 6.4% [4]. - The consensus estimate for earnings is 33 cents per share, indicating a year-over-year increase of 6.5% [4]. Earnings Prediction Insights - The current Earnings ESP for PCG is 0.00%, making it challenging to predict an earnings surprise despite anticipated sales growth [5][9]. - PCG holds a Zacks Rank of 3, suggesting a neutral outlook [6]. Industry Comparisons - American Electric Power (AEP) is expected to report on July 30, with an Earnings ESP of +10.63% and a Zacks Rank of 3 [7]. - IDACORP Inc. (IDA) is also reporting on July 31, with an Earnings ESP of +4.55% and a Zacks Rank of 3 [10]. - Xcel Energy Inc. (XEL) is scheduled for July 31, with an Earnings ESP of +1.76% and a Zacks Rank of 3 [11].

Core Insights - Royal Caribbean Cruises Ltd. (RCL) is set to release its second-quarter 2025 results on July 29, with an expected earnings per share (EPS) of $4.10, reflecting a 27.7% increase from $3.21 in the same quarter last year [1][5] - The consensus estimate for second-quarter revenues is $4.55 billion, indicating a 10.7% growth year-over-year [5] Earnings Estimates - The Zacks Consensus Estimate for RCL's EPS has increased by 1.5% over the past 60 days [1] - The earnings surprise history shows that RCL has outperformed the Zacks Consensus Estimate in the last four quarters, with an average surprise of 8.7% [5][7] Revenue and Growth Factors - Continued strength in close-in demand, strong pricing across key itineraries, and growing onboard revenue contributions are expected to support RCL's second-quarter performance [11] - The introduction of new vessels like Icon of the Seas and Utopia of the Seas is anticipated to positively impact yields, with expected yield growth of 4.3% to 4.8% year-over-year [13] - Passenger ticket revenues are projected to rise 11.1% year-over-year to $3.2 billion, while onboard and other revenues are expected to increase by 6.9% to $1.3 billion [14] Margin Expectations - Operating margins are predicted to expand by 150 basis points year-over-year to 28.2%, supported by scale efficiencies and effective cost management [15] - Net cruise costs excluding fuel are expected to rise by 3.7% to 4.2% year-over-year due to dry dock activity and new ship ramp-up costs [16] Stock Performance and Valuation - RCL shares have increased by 61.5% over the past three months, outperforming the Zacks Leisure and Recreation Services industry, which rose by 29.7% [18] - The stock is currently trading at a forward 12-month price-to-earnings (P/E) multiple of 20.76X, above the industry average of 20.20X [21] Strategic Focus - RCL aims to capture a larger share of the $2 trillion global vacation market through strategic fleet expansion and premium onboard offerings [23] - The company’s diversified deployment strategy, particularly in high-demand regions like the Caribbean, is expected to support continued yield growth [23]

Key Takeaways Starbucks will report Q3 fiscal 2025 results on July 29, with EPS expected to decline 31.2% year over year.SBUX revenues are expected to rise 1.9% to $9.29B, driven by new stores and continued menu innovation. Margin pressure from labor, tariffs and inflation is likely to have impacted profitability.Starbucks Corporation (SBUX) is scheduled to report third-quarter fiscal 2025 results on July 29, 2025, after the closing bell. In the last reported quarter, the company’s earnings missed the Zacks ...

Core Insights - Everest Group, Ltd. (EG) is anticipated to show revenue growth but a decline in earnings for Q2 2025, with revenues expected at $4.40 billion, reflecting a 4.1% increase year-over-year [1] - The consensus estimate for earnings per share is $15.14, indicating a 10.1% decline compared to the previous year [2] Revenue and Earnings Estimates - The Zacks Consensus Estimate for EG's second-quarter revenues is $4.40 billion, marking a 4.1% growth from the prior year [1] - The earnings estimate has decreased by 0.06% over the last 30 days, suggesting a year-over-year decline of 10.1% [2] Earnings Prediction Model - The model indicates a potential earnings beat for Everest Group, supported by a positive Earnings ESP of +0.85% and a Zacks Rank of 3 (Hold) [3][4] Segment Performance - The Reinsurance and Insurance segments are expected to drive premium growth, with net written premiums projected to rise 6.6% to $4.3 billion [5][11] - The Insurance segment is likely to see premiums earned increase by 0.6% to $915.1 million, while the Reinsurance segment is expected to improve by 12.6% to $3 billion [6][7] Investment Income and Underwriting Profitability - Net investment income is anticipated to be $475.6 million, slightly below the Zacks Consensus Estimate of $495 million, influenced by higher income from fixed maturity investments [8] - The combined ratio is expected to improve to 85.4, indicating enhanced underwriting profitability due to rate increases and exposure growth [9][11] Claims and Expenses - Total claims and expenses are projected to rise by 3.2% to $3.5 billion, driven by higher incurred losses and other underwriting expenses [12]

Core Viewpoint - Prudential Financial Inc. (PRU) is anticipated to report a decline in both revenue and earnings for the second quarter of 2025, with revenues expected to be $13.53 billion, reflecting a 2.2% decrease year-over-year, and earnings per share projected at $3.21, indicating a 5.3% decline from the previous year [1][2]. Financial Performance Expectations - The Zacks Consensus Estimate for PRU's second-quarter revenues is $13.53 billion, which is a 2.2% drop from the year-ago figure [1]. - The consensus estimate for earnings per share is $3.21, suggesting a year-over-year decrease of 5.3% [2]. - The earnings estimate has decreased by 7.2% in the past week [2]. Earnings Prediction Model - The earnings prediction model indicates that PRU is not likely to beat earnings expectations this quarter, as it has an Earnings ESP of 0.00% and a Zacks Rank of 3 (Hold) [3][4]. Factors Influencing Q2 Results - The U.S. business is expected to benefit from higher net investment spread results, favorable reserve experience, improved underwriting results, and lower expenses across various segments, although these positives may be offset by higher overall expenses and lower net fee income [5]. - International operations are likely to face challenges from lower net investment spread results, adverse foreign currency exchange impacts, and reduced earnings from joint ventures [6]. Segment Performance Insights - The Individual Retirement Strategies business is projected to see benefits from higher net investment spread results and increased income from non-coupon investments, though this may be partially countered by lower short-term interest rates [7]. - PGIM is expected to experience earnings growth driven by solid asset management fee growth and favorable investment performance, with assets under management benefiting from market appreciation and strong inflows [9]. Investment Income and Expenses - Net investment income is anticipated to rise by 8.2% to $4.5 billion, supported by growth in indexed variable annuities and higher income from non-coupon investments [8]. - Total expenses are expected to reach $12 billion, influenced by higher policyholders' benefits and amortization of deferred policy acquisition costs [10].

Core Viewpoint - Xcel Energy (XEL) is expected to report its second-quarter 2025 results on July 31, following a previous quarter with a negative earnings surprise of 9.7% [1] Factors Impacting Q2 Performance - The residential electric and natural gas bills in Xcel Energy's operating regions are lower than the national average, attracting new customers and positively impacting top-line performance [2] - Increased demand from data centers, the rise of electric vehicles, and regional economic growth are also anticipated to contribute positively to earnings [3] - However, higher operation and maintenance expenses, along with increased depreciation and interest costs, may offset some of these positive factors [3] Q2 Expectations - The Zacks Consensus Estimate for earnings is set at 62 cents per share, reflecting a year-over-year increase of 14.8% [4] - Revenue is projected to reach $3.31 billion, indicating a year-over-year improvement of 9.3% [4] Earnings Prediction - The earnings model predicts a potential earnings beat for Xcel Energy, supported by a positive Earnings ESP of +1.76% and a Zacks Rank of 3 (Hold) [5][6] Other Industry Considerations - Eversource Energy (ES) and IDACORP (IDA) are also expected to report earnings beats, with respective Earnings ESPs of +0.26% and +2.34% [7][10] - Consolidated Edison (ED) is projected to have an Earnings ESP of +3.88% [10]

Core Viewpoint - Exelon Corporation (EXC) is set to release its second-quarter 2025 results on July 31, with expectations of a mixed performance in earnings and revenue [1][4]. Factors Impacting Q2 Performance - Exelon's earnings are anticipated to benefit from a reduction in volumetric risk, with approximately 78% of its distribution revenues decoupled [2]. - The implementation of new gas and electric rates in EXC's service areas is expected to positively influence its bottom line [2]. - Ongoing energy efficiency programs and increased demand from data centers are likely to contribute to the company's performance [3]. Q2 Expectations - The Zacks Consensus Estimate for Exelon's earnings is 43 cents per share, reflecting a year-over-year decrease of 8.5% [4]. - Revenue estimates are projected at $5.83 billion, indicating a year-over-year improvement of 8.7% [4][8]. Earnings Prediction Model - The current Earnings ESP for Exelon is -11.58%, suggesting that the company may not exceed earnings estimates this quarter [5][8]. - Exelon holds a Zacks Rank of 3, indicating a neutral outlook [6]. Industry Comparisons - Other companies in the industry, such as Eversource Energy (ES) and IDACORP (IDA), are expected to report earnings beats, with respective Earnings ESPs of +0.26% and +2.34% [7][9].

Core Viewpoint - Merck is set to report its second-quarter 2025 earnings on July 29, with consensus estimates for sales at $15.77 billion and earnings per share (EPS) at $1.99, reflecting a decline in earnings estimates over the past month [1][6]. Earnings Estimates and Trends - The current EPS estimate for Q2 is $1.99, down from $2.03 30 days ago, indicating a downward trend in earnings expectations [2]. - The average earnings surprise over the last four quarters is 3.82%, with the last quarter showing a surprise of 3.26% [3]. Factors Influencing Upcoming Results - Keytruda, Merck's leading cancer drug, is expected to drive top-line growth in Q2, with sales estimates for Keytruda at $7.90 billion [5][7]. - Other drugs like Lynparza and new products such as Capvaxive are anticipated to contribute positively to pharmaceutical sales [6][14]. Performance of Specific Products - Sales of Keytruda are likely boosted by its uptake in early-stage non-small cell lung cancer and continued demand in metastatic indications [7]. - The HPV vaccine Gardasil is expected to see mixed results, with lower demand in China but increased sales in other markets [10]. - Generic competition is impacting sales of certain products, such as Bridion, while new drugs like Winrevair and Capvaxive are showing promising sales growth [11][13]. Valuation and Market Performance - Merck's shares have underperformed the industry and the S&P 500, with a year-to-date loss of 13.9% [16][22]. - The company's price/earnings ratio of 9.05 is lower than the industry average of 15.25, suggesting potential attractiveness from a valuation perspective [17]. Strategic Developments - Merck's acquisition of Verona Pharma for approximately $10 billion is expected to enhance its cardio-pulmonary pipeline [21][23]. - Despite the strength of Keytruda, there are concerns regarding the company's reliance on this drug and the need for diversification [20][24]. Long-Term Outlook - While Merck faces challenges such as declining sales for Gardasil in China and potential competition for Keytruda, the company is expected to maintain strong sales until Keytruda's patent expiration in 2028 [26][27]. - Long-term investors are encouraged to stay invested, while short-term investors may consider selling due to immediate challenges [27].

Core Insights - Fair Isaac Corporation (FICO) is expected to report its third-quarter fiscal 2025 results on July 30, with projected revenues of $518.8 million, reflecting a 15.8% increase year-over-year, and earnings per share (EPS) of $7.73, indicating a 23.7% growth from the previous year [1][9]. Revenue and Earnings Expectations - The Zacks Consensus Estimate for FICO's third-quarter fiscal 2025 revenues is $518.8 million, suggesting a 15.8% increase from the same quarter last year [1]. - The consensus estimate for earnings is $7.73 per share, which is a 23.7% year-over-year growth, although it has decreased slightly over the past 30 days [1]. Recent Performance Trends - FICO's earnings have missed the Zacks Consensus Estimate in three of the last four quarters, with an average negative surprise of 0.97% [2]. - The company's third-quarter performance is anticipated to benefit from sustained growth in Scores revenues, driven by the adoption of advanced scoring solutions and strong consumer demand [3]. Sector-Specific Developments - In the second quarter of fiscal 2025, FICO saw strong momentum in the adoption of FICO Score 10T, particularly in the mortgage sector, with new lenders joining the early-adopter program, which is expected to continue into the third quarter [4]. - Professional Services revenues are likely to rise sequentially in the upcoming quarter due to prior delays that pushed revenue recognition into the new quarter [5]. - Despite a cautious macro environment, FICO's Software business remains resilient, with expectations of stronger annual recurring revenue growth supported by a healthy deal pipeline and solid net retention among existing clients [6]. Earnings Prediction Model - According to the Zacks model, FICO currently has an Earnings ESP of -1.71% and a Zacks Rank of 3, indicating lower odds of an earnings beat [7].

Core Insights - Teradyne (TER) is set to report its second-quarter 2025 earnings on July 29, with expected revenues between $610 million and $680 million and non-GAAP earnings between 41 cents and 64 cents per share [1][7] - The Zacks Consensus Estimate for revenues is $646.1 million, reflecting an 11.5% decrease from the same quarter last year [1] - The consensus for second-quarter earnings is 54 cents per share, indicating a significant year-over-year decline of 37.21% [2] Revenue and Earnings Expectations - Teradyne anticipates a decline in Memory test system revenues due to customers utilizing existing high-bandwidth memory test capacity instead of investing in new systems [3] - In the Mobile segment, lower revenues are expected, with ongoing uncertainty regarding end-market demand [3][7] Cost and Margin Outlook - The company expects a slight increase in cost of sales and operating expenses for the second quarter of 2025, while gross margin is projected to decrease sequentially due to product mix and lower volume [4][7] Earnings Surprise Potential - According to the Zacks model, Teradyne currently has an Earnings ESP of 0.00% and a Zacks Rank of 3, indicating lower odds of an earnings beat [5]